Stock Earnings

Question 1

What are Corcept Therapeutics Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Corcept Therapeutics Inc has a total asset of $836, Net profit of $99

Question 2

What are the key financial ratios for CORT?

Accepted Answer

Corcept Therapeutics Inc's Current ratio is 4.44, has a Net margin is 13, sales per share of $6.34.

Question 3

How is Corcept Therapeutics Inc's revenue broken down by segment or geography?

Accepted Answer

Corcept Therapeutics Inc largest revenue segment is Pharmaceutical Products, at a revenue of 761,407,000 in the most earnings release.For geography, United States is the primary market for Corcept Therapeutics Inc, at a revenue of 761,407,000.

Question 4

Is Corcept Therapeutics Inc profitable?

Accepted Answer

yes, according to the latest financial statements, Corcept Therapeutics Inc has a net profit of $99

Question 5

Does Corcept Therapeutics Inc have any liabilities?

Accepted Answer

yes, Corcept Therapeutics Inc has liability of 188

Question 6

How many outstanding shares for Corcept Therapeutics Inc?

Accepted Answer

Corcept Therapeutics Inc has a total outstanding shares of 105.96

Breakdown	TTM	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021
Revenue	830	761	675	482	401	366
Revenue Growth (YoY)	16%	13%	40%	20%	10%	4%
Cost of Revenue	14	12	10	6	5	5
Gross Profit	816	748	664	475	396	360
Selling, General & Admin	556	448	280	184	152	122
Research & Development	253	254	246	184	131	113
Operating Expenses	810	703	527	368	283	236
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	26	66	161	124	116	125
Income Tax Expense	-28	-33	20	18	14	12
Net Income	55	99	141	106	101	112
Net Income Growth	-59%	-30%	33%	5%	-10%	6%
Shares Outstanding (Diluted)	118.38	119.98	113.48	111.74	116	126
Shares Change (YoY)	-2%	6%	2%	-4%	-8%	1%
EPS (Diluted)	0.46	0.83	1.24	0.94	0.87	0.89
EPS Growth	-57.99%	-33%	31%	9%	-2%	5%
Free Cash Flow	106	141	196	126	119	167
Free Cash Flow Per Share	0.89	1.17	1.72	1.12	1.02	1.32
Gross Margin	98.31%	98.29%	98.37%	98.54%	98.75%	98.36%
Operating Margin	0.72%	5.78%	20.14%	22.19%	27.93%	33.87%
Profit Margin	6.62%	13%	20.88%	21.99%	25.18%	30.6%
Free Cash Flow Margin	12.77%	18.52%	29.03%	26.14%	29.67%	45.62%
EBITDA	8	45	136	108	112	125
EBITDA Margin	0.96%	5.91%	20.14%	22.4%	27.93%	34.15%
D&A For EBITDA	2	1	0	1	0	1
EBIT	6	44	136	107	112	124
EBIT Margin	0.72%	5.78%	20.14%	22.19%	27.93%	33.87%
Effective Tax Rate	-107.69%	-50%	12.42%	14.51%	12.06%	9.6%

Corcept Therapeutics Inc (CORT) Price

CORT Stock Price Chart

CORT Income

Follow-Up Questions